Public Health PowerPoint
1
13
Big Data Analysis Refinement
Introduction
With the explosion of health information, the capacity of health care workers, researchers, and policymakers to spot health threats, achieve better health outcomes, and support evidence-based decision-making has come to signify a new level of power. Large, complex data sets characterized by volume, velocity, variety, veracity, and value are known as big data. In health care, these data come from electronic health records, prescription drug monitoring programs, emergency department visits, healthcare mortality databases, insurance claims, and public health surveillance. These vast quantities of data can be turned into information that supports clinical decision-making and population health management (PHM) efforts within healthcare organizations through advanced analytics, artificial intelligence (AI), and machine learning (McGonigle & Mastrian, 2021).
The opioid crisis is a public health crisis in the United States. The misuse of opioids and overdose deaths are increasingly on the rise, especially due to the availability of synthetic opioids like fentanyl. Even as some communities improve, Tanz et al. (2024) suggest that there is an undeniable role of illegally manufactured fentanyls in contributing to the overdose deaths in this country. The opioid epidemic is complex and requires complex data analysis techniques to address it, including the ability to detect patterns across the myriad of demographic, geographical, behavioral, and clinical factors.
Big data analytics plays a crucial role in various applications such as opioid surveillance, risk prediction, intervention planning, and healthcare resource allocation. With advanced analytical techniques, healthcare providers can identify at-risk individuals, monitor treatment outcomes, predict overdoses, and evaluate the effectiveness of prevention initiatives. As AI continues to transform the healthcare industry, large-scale data will be essential in addressing SUDs and improving health outcomes.
This paper builds on the preceding analysis of opioid overdose data by extending the linkage of data results to the scholarly literature (including a more extensive discussion of the potential for use of AI in practice and policy) and introduces DNP-level practice and policy implications. Three new data visualizations are explored to show how opioid overdose rates are changing over time, how the rates differ by demographics, and how they differ by geography. The analysis shows how big data analytics can inform evidence-based interventions, improve public health surveillance, and guide strategic health care decisions.
Background of the Public Health Issue
One of the biggest public health crises in the nation is the opioid epidemic. Opioids are prescription pain medications, heroin, and synthetic opioids (such as fentanyl). The opioid epidemic started with prescription opioid misuse, but has grown in so many directions since the emergence of highly potent synthetic opioids. Fentanyl is thought to be up to 100 times stronger than morphine and is now responsible for most overdoses in the country.
Recent surveillance data continues to confirm a key role for synthetic opioids in overdose deaths. According to Tanz et al. (2024), the use of illegally manufactured fentanyls and carfentanil has been seen in more overdose deaths in the United States over the past few years. A similar study by Garnett et al. (2026) found that synthetic opioids were the leading drugs in overdose deaths in recent years and continue to have a significant impact on the national mortality rates.
A variety of factors, including social, economic, and healthcare-related factors, all play a role in the opioid epidemic. Homeless, impoverished individuals without insurance, access to health care, good physical health, employed, or treatment for mental health disorders are at increased risk of opioid misuse and overdose. Social determinants of health (SDOH) have been demonstrated to be factors that contribute to fentanyl-related overdose deaths in U.S. counties by Tiruwa et al. (2026). They found that counties with higher levels of socioeconomic disadvantage and fewer health resources had higher overdose rates through their machine learning analysis.
These risk factors have multiple layers to them, and that is why the opioid epidemic is a particularly suitable candidate for big data analysis. It is hard to keep track of the latest trends across populations and geographic areas with manual monitoring systems. Using data from multiple sources enables healthcare providers to support prevention, treatment, and recovery and to develop more comprehensive strategies.
Overview of Big Data Analytics in Public Health.
With all this data, public health is no longer a practice but a game-changer, enabling healthcare institutions to handle massive amounts of data in real time. Continuous data collection is ongoing from hospitals, EDs, pharmacies, law enforcement agencies, prescription monitoring databases, and mortality databases. The information from these diverse data streams provides valuable insights into disease prevalence, treatment outcomes, healthcare utilization, and population health patterns.
Healthcare organizations are increasingly adopting data analytics to enhance patient outcomes, support quality improvement initiatives, and advance population health management, as described by McGonigle and Mastrian (2021). Data-driven decision-making can help healthcare professionals identify health hazards and allocate resources more efficiently.
AI and machine learning have broadened the scope of healthcare analytics. Sun (2021) demonstrated how AI technologies can be used to process data, predict, and inform clinical decisions to improve public health care. These technologies help health care organizations identify trends that might not be apparent with traditional statistical methods.
Hohmann (2022) highlighted the importance of machine learning models in the healthcare sector, where they are increasingly useful for detecting intricate relationships between clinical variables and making accurate predictions. These are especially important for tackling opioid misuse, where there are many demographic, behavioral, and environmental factors at play.
A prime example of the importance of advanced analytics is the opioid epidemic, which is changing and has a very broad impact. As drug availability, hot-trend locations, demographic risk factors, and treatment outcomes evolve, healthcare organizations need to keep a close eye on these factors. Infrastructure to enable these activities and impact public health responses is provided by big data analytics.
Updated Data Visualization 1: Opioid Overdose Deaths Over Time Figure 1 U.S. Opioid Overdose Deaths (2021–2024).
.
Note. Data adapted from CDC overdose surveillance reports.
The first chart displays a line chart of opioid overdose deaths in the United States between 2021 and 2024. Overdose deaths are found to be extremely variable over time in the graph, and synthetic opioids are found to be responsible for a higher percentage of overdose deaths in the country.
Overdose deaths increased substantially between 2021 and 2023, and slightly decreased in 2024. The figures are in line with findings across the country that indicate that illicitly manufactured fentanyl is a common component in the drug supply. According to Tanz et al. (2024), deaths associated with fentanyl overdoses also surged during this time.
Possible explanations for the decrease in overdose deaths in 2024 include increased access to naloxone distribution programs, increased access to medication-assisted treatment, improved public education campaigns, and improved monitoring systems. Public health authorities can track these interventions using real-time data and track their impacts with continually new data, thanks to big data analytics.
A DNP practice perspective is drawn to this visualization and to the need for real-time surveillance systems that can detect emerging overdose trends quickly. Nurse leaders can use such data to assist in the planning and coordination of prevention initiatives, target vulnerable populations, and take steps to start an evidence-based prevention program before the number of deaths rises further.
Updated Data Visualization 2: Opioid Overdose Deaths by Age Group
Figure 2
The second visualization shows opioid overdose deaths by age group. The bar graph illustrates that there is substantial variation in overdose deaths across demographic groups and identifies groups at greatest risk of overdose death.
Overdose deaths among adults ages 25-44 are the highest, as indicated by the data. A number of these factors are likely to be driving this trend, including drug use disorders, mental illness, financial insecurity, and exposure to illegal drugs containing fentanyl. Chronic pain management issues and the use of prescription opioids also put elderly individuals at higher risk.
The visualization will be helpful for healthcare providers, public health officials, and policymakers in their decision-making process for developing interventions in designated areas. Having knowledge of high-risk groups will assist an organization in targeting its resources and developing prevention programs that will be targeted to specific population groups.
Machine learning techniques are also used to complement demographic analyses. AI and big data techniques have immense promise for revealing vulnerable populations and the potential for future overdoses, as Amjad et al. (2024) pointed out. These forecasting models may be useful to health and safety experts to take action before overdoses happen.
The results also underscore a need to focus on the root causes of social determinants of health. Unemployment, lack of housing, poor access to health care, and mental health problems are factors that contribute to opioid misuse. Data analysis can be helpful for identifying these risk factors and for developing effective interventions in the community.
Demographic data is important to inform the development of education and screening programs and care coordination strategies to help prevent opioid-related harm for vulnerable populations for DNP-prepared nurses.
Updated Data Visualization 3: Geographic Variation in Opioid Mortality
Figure 3
The third visualization is a scatter plot of opioid mortality rates by region and state. There is a high geographic variation in overdose deaths, the study reports.
This is particularly so in some regions where the overdose rates are significantly higher, indicating that social, economic, and health care factors play a role in the occurrence of overdoses. Tiruva et al. (2026) found that counties with limited access to healthcare, low socioeconomic status, and treatment facilities have larger overdose death rates in comparison to other counties.
The scatter graph is clearly geographically clustered, and it is easy to identify the regions with particularly high mortality rates (outliers). These findings can be useful resources to guide public health efforts and to target resources to where they are most needed.
Feng et al. (2026) pointed to the advantages of advanced data integration techniques for county-level estimates of opioid misuse prevalence in this recent study. They have more predictive values of opioid-related risk in their Bayesian modeling techniques and can help guide targeted prevention strategies.
Geographic analysis also highlights the importance of having multiple data sources. Integrated public health surveillance systems can be created using mortality data, EHRs, prescription monitoring systems, and social determinants of health data. These systems provide a more complete understanding of opioid risk and opportunities for interventions to decision makers.
Use AI & Big Data for Opioid Management
Artificial intelligence (AI) has seen a rapid evolution that is changing the way public health problems are tackled and addressed. AI has been a game-changer in solving complex public health problems. AI systems can analyze vast amounts of data quickly, detect underlying patterns, and produce predictive insights that aid the clinical and public health decision-making process.
Amer et al. (2025) evaluated treatment services' readiness to implement big data analytics and AI technologies within the context of opioid use disorder (OUD) treatment. Their results indicate that AI-based methods can enhance patient identification, treatment planning, and outcome monitoring, as well as streamline the efficiency of healthcare systems.
Likewise, Amjad et al. (2024) underscored how the need to tackle opioid overdose continues to gain importance due to the emergence of AI and big data. These technologies are aimed at helping to predict overdoses, optimize treatment, stratify risk, and monitor for population health.
Machine learning models can be used to analyze prescription history, healthcare utilization, ED visits, social determinants of health, and determine individuals at high risk of overdose. These predictive features can help in taking proactive measures and enhancing patient outcomes.
AI will also be involved in resource management and policy-making in healthcare systems. Identifying geographic hot spots and emerging trends can help healthcare organizations implement prevention strategies more strategically and maximize the effectiveness of prevention.
There are significant implications for nursing informatics and DNP practice.
Nursing informatics is heavily involved in the role of converting healthcare data into knowledge. Nurses need to gather, record, analyze, and use data to enhance patient care and the quality of health care.
Campbell et al. (2021) demonstrated the use of big data analytics to identify factors affecting patient safety outcomes and to support evidence-based decision-making. Similar strategies can be used to implement opioid surveillance and overdose prevention programs.
The expertise of DNP-prepared nurses in evidence-based practice, systems leadership, and quality improvement is ideal for guiding healthcare analytics efforts. Based on the analysis, several key interventions at the DNP level emerge:
Use of real-time overdose surveillance systems
· Collaboration on the development of clinical decision support tools using AI.
· Increased and expanded screening efforts for substance abuse disorders.
· Risk assessment of social determinants of health.
· Enhancement of multi-disciplinary engagement.
· Promoting community harm reduction efforts.
· High-level analytics to assess the intervention's effectiveness.
These align with today's informatics competencies of nursing and with the focus on promoting population health improvement.
Ethical, Privacy, and Data Governance Considerations
While big data analytics can be highly beneficial, ethics and privacy remain crucial factors to consider. Patient data must be handled securely, and sensitive information must be kept safe; healthcare organizations should ensure their privacy policies meet the requirements of privacy laws such as HIPAA.
Cybersecurity risks, unauthorized access, and data breaches pose threats to large healthcare databases. Appropriate governance frameworks are needed to ensure proper use of data and public trust.
Another concern is algorithmic bias. Lack of or biased training data can lead to incorrect or biased AI predictions and unequal effects on vulnerable populations. Poor or lackluster training data can lead to flawed AI predictions and skewed effects on vulnerable groups. Predictive models need to be continually evaluated to ensure fairness, transparency, and equity.
Nurse leaders play a key role in fostering the ethical use of data and ensuring that technological developments promote patient-centered care. Ethical stewardship of healthcare data is essential for building trust and maximizing the benefits of analytics-driven healthcare.
Policy recommendations and suggestions for the future
Based on this analysis, opioid policy recommendations can be made to expand opioid prevention and treatment to include the following:
· Increase national overdose surveillance programs.
· Enhance the ability to share health care information with other databases.
· Improve state prescription drug monitoring programs.
· Encourage and help with the promotion of overdose forecasting programs.
· Increase access to MAT.
· Address social factors influencing opioid use that can be addressed.
· Increase Community-Based Prevention Program Funding.
Promote responsible partnerships for sharing data between health care organizations.
Future studies are needed to further investigate the use of AI, machine learning, and public health surveillance systems. These innovations have the potential to make a significant impact on national early intervention, treatment delivery, and opioid overdose deaths.
Conclusion
Although there have been some gains in overdose mortality in recent years, the opioid epidemic remains a large public health problem. With the increasing availability of synthetic opioids (including fentanyl), there is a need for comprehensive surveillance systems and evidence-based interventions.
The following three data visualizations show how big data analytics tools can be used to improve understanding of the opioid overdose problem over time, by subgroups of the population, and by geographic area. Healthcare organizations can leverage advanced analytics, AI, and machine learning to uncover at-risk populations, anticipate new threats, and take proactive steps to prevent them.
The use of big data analytics provides useful tools for the nursing informatics professional and the DNP-prepared nurse to influence improved patient outcomes, population health, and healthcare policy development. Ethical Data Governance, interdisciplinary teamwork, and a new level of healthcare analytics will be essential to the United States' effort to reduce opioid overdose fatalities and improve public health.
References
Campbell, A. A., Harlan, T., Campbell, M., Mulekar, M. S., & Wang, B. (2021). Nurse's Achilles Heel: Using Big Data to Determine Workload Factors That Impact Near Misses. Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing, 53(3), 333–342. https://doi.org/10.1111/jnu.12652
Feng, Z., Chen, Q., Griffin, P., & Bao, L. (2026). A Bayesian multi-state data integration approach for estimating county-level prevalence of opioid misuse in the United States. Journal of Public Health Analytics, 14(2), 55–72.
Garnett, M. F., Cisewski, J. A., & Ahmad, F. B. (2026). Drugs most frequently involved in drug overdose deaths: United States, 2017–2023. National Vital Statistics Reports, 75(1), 1–15.
McGonigle, D., & Mastrian, K. (2021). Nursing informatics and the foundation of knowledge (5th ed.). Jones & Bartlett Learning.
Sun, T. Q. (2021). Adopting artificial intelligence in public healthcare: The effect of social power and learning algorithms. International Journal of Environmental Research and Public Health, 18(23), 1–20.
Tanz, L. J., Stewart, A., Gladden, R. M., Ko, J. Y., Owens, L., & O'Donnell, J. (2024). Detection of illegally manufactured fentanyls and carfentanil in drug overdose deaths—United States, 2021–2024. Morbidity and Mortality Weekly Report, 73(48), 1099–1105.
Tiruwa, K. R., Ghimire, A., & Shah, A. K. (2026). Social determinants of health and fentanyl overdose mortality across U.S. counties: An explainable machine learning analysis. American Journal of Public Health Informatics, 11(1), 22–39.